Effect
of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected
with HIV in Early Life.
Unsal AB, Mattingly AS, Jones SE,
et al
J Clin Endocrinol Metab.
2017 May
Abstract
Use of antiretroviral therapy and risk of end-stage liver disease and
hepatocellular carcinoma in HIV-positive persons.
Ryom L, Lundgren JD, De Wit S, et al
AIDS. 2016 Jan 8.
Abstract
Liver Fibrosis in HIV Patients Receiving a Modern cART: Which
Factors Play a Role?
Mohr R, Schierwagen R, Schwarze-Zander C,
et al
Medicine (Baltimore). 2015 Dec;94(50):e2127
Abstract
Baseline prevalence and predictors of liver fibrosis among
HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of
AntiRetroviral Treatment (START) trial.
Matthews G, Neuhaus J, Bhagani S, et al
HIV Med.
2015 Apr;16 Suppl 1:129-36.
Abstract
Will antiretroviral therapy reduce HIV-related liver risk?
Allen J, Smith C, Bhagani S.
Curr Opin HIV AIDS.
2013 Nov 15..
Abstract
FULL-TEXT ARTICLE
HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal,
and Pancreatic Injury.
Neuman MG, Schneider M, Nanau RM, Parry C.
Int J Hepatol.
2012;2012:760706.
Paper
Influence of antiretroviral therapy on liver
disease.
Kovari H, Weber R.
Curr Opin HIV AIDS.
2011 Apr 20
Abstract
Clinical syndromes and consequences of
antiretroviral-related hepatotoxicity.
Núñez M.
Hepatology.
2010 Sep;52(3):1143-55.
Abstract |
General
Reports
HAART
Adverse Events
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader